Published in Leuk Lymphoma on May 01, 2007
Thoracic t(9;22)-positive granulocytic sarcoma as initial presentation of chronic myeloid leukemia. Clin Lymphoma Myeloma Leuk (2013) 0.81
BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. Virchows Arch (2015) 0.79
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia. Mol Ther Nucleic Acids (2017) 0.75
The YEASTRACT database: a tool for the analysis of transcription regulatory associations in Saccharomyces cerevisiae. Nucleic Acids Res (2006) 4.53
Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alström syndrome. Hum Mutat (2007) 2.20
Piebaldism and neurofibromatosis type 1: family report. Dermatol Online J (2010) 2.07
Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1. Leuk Lymphoma (2011) 1.00
Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology (2013) 0.99
Saccharomyces cerevisiae multidrug resistance transporter Qdr2 is implicated in potassium uptake, providing a physiological advantage to quinidine-stressed cells. Eukaryot Cell (2006) 0.99
The RIM101 pathway has a role in Saccharomyces cerevisiae adaptive response and resistance to propionic acid and other weak acids. FEMS Yeast Res (2009) 0.99
Saccharomyces cerevisiae multidrug transporter Qdr2p (Yil121wp): localization and function as a quinidine resistance determinant. Antimicrob Agents Chemother (2004) 0.94
Developmental absence of maxillary lateral incisors in the Portuguese population. Eur J Orthod (2005) 0.94
Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation. Eur J Dermatol (2009) 0.89
High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort. BMC Med Genet (2012) 0.88
Non-secretory multiple myeloma relapsing as extramedullary liver plasmacytomas. J Gastrointestin Liver Dis (2011) 0.87
Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib. Oncol Rep (2012) 0.87
A proteome analysis of the yeast response to the herbicide 2,4-dichlorophenoxyacetic acid. Proteomics (2005) 0.83
Vascular Ehlers-Danlos syndrome: a case with fatal outcome. Dermatol Online J (2011) 0.80
Polymerase chain reaction screening for fungemia and/or invasive fungal infections in patients with hematologic malignancies. Support Care Cancer (2006) 0.80
Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction. Clin Med Insights Oncol (2010) 0.80
Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach. Drug Metabol Drug Interact (2013) 0.80
Cobalt complexes bearing scorpionate ligands: synthesis, characterization, cytotoxicity and DNA cleavage. Dalton Trans (2012) 0.79
Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction. Mutat Res (2005) 0.79
DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells. Leuk Lymphoma (2012) 0.79
Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol. Mutagenesis (2006) 0.79
Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting. Rev Port Cardiol (2011) 0.78
Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies. J Biol Inorg Chem (2014) 0.78
Characterization of antiproliferative potential and biological targets of a copper compound containing 4'-phenyl terpyridine. J Biol Inorg Chem (2015) 0.76
Estragole: a weak direct-acting food-borne genotoxin and potential carcinogen. Mutat Res (2012) 0.76
DNA-PK inhibitor wortmannin enhances DNA damage induced by bleomycin in V79 Chinese hamster cells. Teratog Carcinog Mutagen (2002) 0.76
Ehlers-Danlos syndrome type IV in association with a (c.970G>A) mutation in the COL3A1 gene. Acta Med Port (2012) 0.76
Piebaldism and neurofibromatosis: state of knowledge. Dermatol Online J (2013) 0.76
A value-added exopolysaccharide as a coating agent for MRI nanoprobes. Nanoscale (2015) 0.76
Kallmann syndrome in a female adolescent: a new mutation in the FGFR1 gene. BMJ Case Rep (2012) 0.75
Advances in the genotyping of thrombosis genetic risk factors: clinical and laboratory implications. Pathophysiol Haemost Thromb (2003) 0.75
Different manifestations of class II division 2 incisor retroclination and their association with dental anomalies. J Orthod (2013) 0.75
Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells. Food Chem Toxicol (2010) 0.75
[Hereditary pancreatitis in a child]. Acta Med Port (2009) 0.75
Erythropoietic protoporphyria: a family study and report of a novel mutation in the FECH gene. Eur J Dermatol (2011) 0.75
Cat eye syndrome and growth hormone deficiency with pituitary anomalies: a case report and review of the literature. Gene (2013) 0.75
Cobalt complexes with pyrazole ligands as catalyst precursors for the peroxidative oxidation of cyclohexane: X-ray absorption spectroscopy studies and biological applications. Chem Asian J (2014) 0.75
Different manifestations of Class II Division 2 incisor retroclination: a morphologic study. Am J Orthod Dentofacial Orthop (2013) 0.75
Sjögren-Larsson syndrome due to a novel mutation in the FALDH gene. Eur J Dermatol (2011) 0.75
Plasma cell meningitis: a rare neurological complication of multiple myeloma requiring a high index of suspicion. Acta Neurol Taiwan (2011) 0.75
Left ventricular non-compaction: a new mutation predisposing to reverse remodeling? Rev Port Cardiol (2009) 0.75